Topiramate 25 mg Immediate Release Tablets is included in the Pill Pass Discount Drug List at Pill Pals Pharmacy. This educational article summarizes key FDA-label topics for patients, caregivers, and prescribers who want a plain-language overview before speaking with a physician or pharmacist.
Drug Name
Topiramate 25 mg Immediate Release Tablets
FDA Labeled Indications
Topiramate immediate-release tablets are FDA-labeled for epilepsy treatment and for prevention of migraine headaches depending on patient age and product labeling.
Contraindications
Contraindications include hypersensitivity to topiramate.
Warnings
Warnings include acute myopia and secondary angle-closure glaucoma, visual field defects, decreased sweating and fever, metabolic acidosis, suicidal behavior and ideation, cognitive and mood effects, kidney stones, serious skin reactions, and fetal harm.
Precautions
Monitor bicarbonate, kidney function, mood, cognition, vision symptoms, hydration, and pregnancy status where relevant. Use caution with kidney disease, liver disease, ketogenic diet, other carbonic anhydrase inhibitors, valproate, and abrupt discontinuation.
Adverse Reactions
Adverse reactions may include tingling, weight loss, appetite loss, fatigue, dizziness, sleepiness, memory or concentration problems, nausea, diarrhea, and taste changes.
Pill Pass Discount Drug List Notes
Availability, quantity limits, manufacturer selection, and final dispensing decisions may depend on prescription requirements, clinical appropriateness, inventory, and applicable law. This article is informational and is not a substitute for individualized medical advice, diagnosis, treatment, or the full FDA-approved labeling for the dispensed product.
Related Pill Pass Discount Drug List Articles
For related medications on the same Pill Pass Discount Drug List, you may also review Topiramate 50 mg Immediate Release Tablets, Topiramate 100 mg Immediate Release Tablets, Tizanidine 4 mg Tablets, and Tizanidine 2 mg Tablets.
Source note: this article is written as a patient-friendly summary of FDA labeling topics available through DailyMed and related FDA labeling resources. Manufacturer-specific labeling can vary, so patients should rely on the medication guide, package insert, prescriber instructions, and pharmacist counseling for their specific product.
Topiramate 25 mg Immediate Release Tablets is on the Pill Pass List. This information is accurate as of May 13, 2026. If you would like more information on this medication, please contact your Physician or Pharmacist.
